These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 1469394)
1. The dopaminergic response in multiple system atrophy. Hughes AJ; Colosimo C; Kleedorfer B; Daniel SE; Lees AJ J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1009-13. PubMed ID: 1469394 [TBL] [Abstract][Full Text] [Related]
2. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. Merello M; Lees AJ J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1024-6. PubMed ID: 1469397 [TBL] [Abstract][Full Text] [Related]
3. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease. Deleu D; Hanssens Y; Northway MG Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576 [TBL] [Abstract][Full Text] [Related]
4. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon. Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329 [TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease. Colzi A; Turner K; Lees AJ J Neurol Neurosurg Psychiatry; 1998 May; 64(5):573-6. PubMed ID: 9598668 [TBL] [Abstract][Full Text] [Related]
6. Motor response following repeated apomorphine administration is reduced in Parkinson's disease. Grandas F; Obeso JA Clin Neuropharmacol; 1989 Feb; 12(1):14-22. PubMed ID: 2713864 [TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges. Katzenschlager R; Hughes A; Evans A; Manson AJ; Hoffman M; Swinn L; Watt H; Bhatia K; Quinn N; Lees AJ Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035 [TBL] [Abstract][Full Text] [Related]
8. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease. Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061 [TBL] [Abstract][Full Text] [Related]
9. Comparison of motor response to apomorphine and levodopa in Parkinson's disease. Kempster PA; Frankel JP; Stern GM; Lees AJ J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):1004-7. PubMed ID: 2283512 [TBL] [Abstract][Full Text] [Related]
10. Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: results of a two-year, prospective follow-up. Kanovský P; Kubová D; Bareš M; Hortová H; Streitová H; Rektor I; Znojil V Mov Disord; 2002 Jan; 17(1):188-91. PubMed ID: 11835461 [TBL] [Abstract][Full Text] [Related]
11. Apomorphine for motor fluctuations and freezing in Parkinson's disease. Corboy DL; Wagner ML; Sage JI Ann Pharmacother; 1995 Mar; 29(3):282-8. PubMed ID: 7606075 [TBL] [Abstract][Full Text] [Related]
12. Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation. Elia AE; Dollenz C; Soliveri P; Albanese A Eur J Neurol; 2012 Jan; 19(1):76-83. PubMed ID: 21645174 [TBL] [Abstract][Full Text] [Related]
13. The motor response to repeated apomorphine administration in Parkinson's disease. Hughes AJ; Bishop S; Stern GM; Lees AJ Clin Neuropharmacol; 1991 Jun; 14(3):209-13. PubMed ID: 2070362 [TBL] [Abstract][Full Text] [Related]
15. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease. Chen JJ; Obering C Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444 [TBL] [Abstract][Full Text] [Related]
16. The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease. Turjanski N; Fernandez W; Lees AJ J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):771-5. PubMed ID: 8331352 [TBL] [Abstract][Full Text] [Related]
17. [Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease]. Pollak P; Champay AS; Gaio JM; Hommel M; Benabid AL; Perret J Rev Neurol (Paris); 1990; 146(2):116-22. PubMed ID: 2320817 [TBL] [Abstract][Full Text] [Related]
18. Apomorphine in the diagnosis and treatment of parkinsonian tremor. Hughes AJ; Lees AJ; Stern GM Clin Neuropharmacol; 1990 Aug; 13(4):312-7. PubMed ID: 2208183 [TBL] [Abstract][Full Text] [Related]
19. [Motor impairment, in patients with severe Parkinson's disease, associated with dopaminergic hyperstimulation (entacapone)]. Vaamonde J; Ibáñez R; Hernández A; Gudín M; de Luis P; del Real MA Neurologia; 2001 Feb; 16(2):81-4. PubMed ID: 11257935 [TBL] [Abstract][Full Text] [Related]
20. Motor response to apomorphine and levodopa in asymmetric Parkinson's disease. Kempster PA; Lees AJ J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1444. PubMed ID: 7964840 [No Abstract] [Full Text] [Related] [Next] [New Search]